Avricore Health Inc.

AVCR

CA0545211090

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 07:05:58 05/07/2024 pm IST			5-day change	1st Jan Change
0.16 ^CAD	-3.03%		-3.03%	-5.88%

03/06	Avricore Health Swings to a First-Quarter Profit	MT
31/05	Avricore Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Avricore Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024

May 31, 2024 at 04:55 am IST

Avricore Health Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CAD 1.12 million compared to CAD 0.629241 million a year ago. Net income was CAD 0.168537 million compared to net loss of CAD 0.191512 million a year ago.

Latest news about Avricore Health Inc.

Avricore Health Swings to a First-Quarter Profit	03/06	MT
Avricore Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	31/05	CI
Avricore Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30/04	CI
Avricore's HealthTab Signs Agreement for More Rexall Pharmacy Locations	04/04	MT
Avricore Health Provides Update on Q3	01/12	MT
Avricore Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11	CI
Avricore Health Inc. Expands Its Innovative Point-Of-Care Chronic and Infectious Disease Screening and Health- Data Management Platform, Healthtab	15/23/15	CI
Avricore Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/23/29	CI
Avricore Health Up Nearly 14% After Reporting Reseller Pact Between HealthTab, Abbott Rapid Dx UK & Ireland	08/23/08	MT
Avricore Health Inc. Announces its Agreement with Ascensia Diabetes Care to Integrate Their Blood Glucose Monitoring Systems, Marketed as Contour Next Gen and Four Next One	04/23/04	CI
HealthTab to Integrate CONTOUR NEXT Family of Blood Glucose Meters For Deeper Diabetes Patient Insights	19/23/19	MT
Avricore Health Inc Announces Agreement with Ascensia Diabetes Cares	19/23/19	CI
Avricore Health Inc. Announces Board Changes	22/23/22	CI
Avricore Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	31/23/31	CI
Avricore Health Inc. Auditor Raises 'Going Concern' Doubt	01/23/01	CI
Avricore Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01	CI
Avricore Health's HealthTab Passes 530 Locations, Adds Virus Detection	24/23/24	MT
Avricore Health Provides Update	01/23/01	MT
Avricore Health Expands the Number of Shoppers Drug Mart Pharmacies Offering Its HealthTab Point-Of-Care Testing Platform Under A Renewed Master Service Agreement	06/23/06	CI
Avricore Health Reports Q3 Results	29/22/29	MT
Avricore Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29/22/29	CI
Avricore Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	27/22/27	CI
Avricore Health Inc. Expands with Shoppers Drug Mart®	08/22/08	CI
Avricore Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/22/27	CI
Avricore Health Inc. Auditor Raises 'Going Concern' Doubt	22/22/22	CI

Chart Avricore Health Inc.

Duration

Period

More charts

Company Profile

Avricore Health Inc. is a pharmacy service company that is focused on acquiring and developing early-stage technologies. The Company is engaged in the business of health data and point-of-care technologies (POCT). It provides digital solutions that support the role of pharmacists and provide infrastructure for making clinical services more accessible and more affordable in its communities. The Company's offering includes HealthTab. HealthTab is a cloud-based network technology that enables the real-time response system where consumers receive a finger-stick blood test at their local pharmacy via a Web-enabled blood chemistry analyzer. Its HealthTab platform can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. It also provides bacterial and viral testing for Strep and COVID-19. The Company's wholly owned subsidiary is HealthTab Inc.

Sector

Pharmaceuticals

Calendar

28/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
AVRICORE HEALTH INC.	-5.88%	12.11M
ELI LILLY AND COMPANY	+56.89%	809B
NOVO NORDISK A/S	+39.52%	624B
JOHNSON & JOHNSON	-6.55%	351B
ABBVIE INC.	+7.92%	289B
ASTRAZENECA PLC	+13.74%	240B
NOVARTIS AG	+13.83%	220B
ROCHE HOLDING AG	-0.49%	219B
AMGEN INC.	+7.94%	166B
PFIZER, INC.	-2.57%	157B

Other Pharmaceuticals